Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

40.01
Delayed Data
As of Jul 31
 +0.21 / +0.53%
Today’s Change
33.75
Today|||52-Week Range
45.43
+6.92%
Year-to-Date

Today’s Trading

Previous close39.80
Today’s open39.90
Day’s range39.60 - 40.11
Volume270,324
Average volume (3 months)302,912
Market cap$2.0B
Dividend yield--
Data as of 4:05pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)+8.92%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-3.00%
P/E ratio123.3
Price/Sales2.53
Price/Book2.44

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc+0.05+0.12%
MASIMasimo Corp-0.01-0.02%
IARTIntegra LifeSciences...+0.13+0.20%
PODDInsulet Corp+0.34+1.01%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)$0.40
Annual revenue (last year)$910.4M
Annual profit (last year)$16.9M
Net profit margin1.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Brian P. Concannon
Chief Operating Officer
Kent J. Davies
Corporate headquarters
Braintree, Massachusetts

Forecasts